Vitamin B12 may protect the brain in old age and reduce risk of dementia, according to a new study by University of Oxford researchers. Published in the new issue of Neurology, the study determined people with higher blood levels of vitamin B12 were six times less likely to experience brain shrinkage compared with people with lower vitamin levels.

According to study author Anna Vogiatzoglou, MSc, University of Oxford, the study suggests consuming more vitamin B12 to prevent brain shrinkage may save memory.

"Research shows that vitamin B12 deficiency is a public health problem, especially among the elderly, so more vitamin B12 intake could help reverse this problem," said Vogiatzoglou.

Doctors are prescribing Animi-3(R) to address nutritional deficiencies including vitamin B12 and other essential nutrients to deficient patients. Each capsule of Animi-3 contains 500 mg of omega-3, (350 mg of DHA), 1 mg of folic acid, 12.5 mg of B6, and 12 mcg of B12.

"This Oxford University study correlates with other clinical findings that point to specific nutrient deficiencies correlated with reduced brain function," said Jack Schramm, President of PBM Pharmaceuticals, the makers of Animi-3. "Studies continue to highlight the role nutritional deficiencies of the Animi-3 nutrients play in those with diminished brain health."

-- Dr. Schaefer, M.D., Tufts University, has analyzed the relationship of DHA to dementia and Alzheimer's disease. His observations from the Framingham Heart Study indicate top quartile plasma DHA levels (correlated with consuming 180 mg/day or more of DHA) are associated with a 50% decreased risk of dementia.
-- Fernando Gomez-Pinilla, UCLA professor of neurosurgery and physiological science, identified nutrients beneficial in preventing mental disorders, including omega-3 (DHA), folic acid, and vitamins B6 and B12. Omega-3 deficiency has been associated with increased risk of attention-deficit disorder, dyslexia, dementia, depression, bipolar disorder, and schizophrenia.
-- Dr. Jane Durga, Wageningen University, published findings from a double-blind, placebo-controlled study in The Lancet that determined cognitive function improved significantly in participants taking folic acid.

More information on Animi-3 ingredients is found on http://www.animi-3.com and on http://www.dhaandbvitamins.org, a resource developed by specialists at Weill Cornell Medical College and other medical centers.

Animi-3 is not intended to diagnose, treat, or cure any disease.
Source:
http://www.aan.com/press/index.cfm?fuseaction=release.view&release=652

Contact:  Joe Shields
Director of Public Relations
(800) 959-2066 ext. 1131
jshields@pbmproducts.com